Search
for
Sort by
Research 871–900 of 1000+
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Comorbid Conditions Associated with Alopecia Areata: A Systematic Review and Meta-analysis
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles
- Malnutrition and Allergies: Tipping the Immune Balance towards Health
- Microneedle Arrays Combined with Nanomedicine Approaches for Transdermal Delivery of Therapeutics
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- A novel predictive model for the recurrence of pediatric alopecia areata by bioinformatics analysis and a single-center prospective study
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Vitiligo—Current Treatment Options and Future Perspectives
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Celiac Disease: Beyond Diet and Food Awareness
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Baricitinib for the Treatment of Alopecia Areata
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Long-acting microneedle formulations
- Frontal Fibrosing Alopecia and the Role of Cosmeceuticals in Its Pathogenesis
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata